MetinOzdemirliMD
Pathology • Washington, DCHematopathology, Anatomic Pathology, Clinical Pathology
Professor, Pathology, Georgetown University Hospital
Are you Dr. Ozdemirli?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-3614
Summary
- Dr. Metin Ozdemirli, MD is a board certified pathologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia and Maryland. He is affiliated with MedStar Georgetown University Hospital and is a Professor at Georgetown University Hospital.
Education & Training
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1995
Boston University School of MedicineClass of 1993
Certifications & Licensure
DC State Medical License 1995 - 2027
MD State Medical License 2023 - 2025
American Board of Pathology Anatomic Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Chronic endothelial inflammation in PWH leads to reduced circulating megakaryocyte progenitor cells.Tong Li, Colleen Hadigan, Jaeil Ahn, Chinmayee Mehta, Makheni Jean Pierre
Blood Vessels, Thrombosis & Hemostasis. 2025-02-01 - Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment.Jinjun Cheng, Sarah Harney, Keri Toner, Paige Kube, Shunyou Gong
Pediatric Blood & Cancer. 2024-08-01 - 9 citationsIndolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.Metin Ozdemirli, Thomas M Loughney, Emre Deniz, Joeffrey J Chahine, Maher Albitar
The New England Journal of Medicine. 2024-06-13
Press Mentions
Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T TherapyJune 13th, 2024- Tragic New Details About Dozens of American Patients Whose Life-Saving Cancer Treatment Caused Them to Develop More CancersJune 13th, 2024
- Immunotherapy to Treat Cancer Gave Rise to 2nd Cancer in Extremely Rare CaseJune 14th, 2024
- Join now to see all
